Additionally, exposure of the estrogen receptor-negative human breast cancer cell line, MDA-MB-231, and medullary thyroid cancer cells, to unmodified Tetrac and nanoparticulate Tetrac (Nanotetrac), which is specifically covalently bound, revealed differential involvement in cancer survival and apoptosis pathways based on effects on gene transcription determined via microarray [149,150]. This evidence concerns the gene ESR1 and breast carcinoma.